These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 18199996)

  • 1. Drug insight: translating evidence on statin therapy into clinical benefits.
    Sanossian N; Ovbiagele B
    Nat Clin Pract Neurol; 2008 Jan; 4(1):43-9. PubMed ID: 18199996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statin therapy and stroke prevention: what was known, what is new and what is next?
    Mazighi M; Lavallée PC; Labreuche J; Amarenco P
    Curr Opin Lipidol; 2007 Dec; 18(6):622-5. PubMed ID: 17993806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of atorvastatin in elderly patients with a recent stroke or transient ischemic attack.
    Chaturvedi S; Zivin J; Breazna A; Amarenco P; Callahan A; Goldstein LB; Hennerici M; Sillesen H; Rudolph A; Welch MA;
    Neurology; 2009 Feb; 72(8):688-94. PubMed ID: 18768917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose statin therapy for secondary prevention of stroke: stroke prevention by aggressive reduction in cholesterol levels study review.
    Schwertz DW; Badellino KO
    J Cardiovasc Nurs; 2008; 23(1):8-13. PubMed ID: 18158500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Secondary prevention of recurrent stroke by lowering cholesterol levels and blood pressure].
    Stalenhoef AF
    Ned Tijdschr Geneeskd; 2006 Sep; 150(39):2127-30. PubMed ID: 17059084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On-treatment lipoprotein components and risk of cerebrovascular events in the Treating to New Targets study.
    van den Bogaard B; van den Born BJ; Fayyad R; Waters DD; DeMicco DA; LaRosa JC; Kastelein JJ; Holme I;
    Eur J Clin Invest; 2011 Feb; 41(2):134-42. PubMed ID: 20868450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The safety and efficacy of achieving very low LDL-cholesterol concentrations with high dose statin therapy.
    Wiviott SD; Cannon CP
    Curr Opin Lipidol; 2006 Dec; 17(6):626-30. PubMed ID: 17095906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of stroke and cardiovascular events after ischemic stroke or transient ischemic attack in patients with type 2 diabetes or metabolic syndrome: secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial.
    Callahan A; Amarenco P; Goldstein LB; Sillesen H; Messig M; Samsa GP; Altafullah I; Ledbetter LY; MacLeod MJ; Scott R; Hennerici M; Zivin JA; Welch KM;
    Arch Neurol; 2011 Oct; 68(10):1245-51. PubMed ID: 21670382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statins and stroke prevention.
    Paciaroni M; Bogousslavsky J
    Expert Rev Cardiovasc Ther; 2009 Oct; 7(10):1231-43. PubMed ID: 19814666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Achieving target cholesterol goals after stroke: is in-hospital statin initiation the key?
    Sanossian N; Saver JL; Liebeskind DS; Kim D; Razinia T; Ovbiagele B
    Arch Neurol; 2006 Aug; 63(8):1081-3. PubMed ID: 16908732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statins and stroke prevention.
    Paciaroni M; Hennerici M; Agnelli G; Bogousslavsky J
    Cerebrovasc Dis; 2007; 24(2-3):170-82. PubMed ID: 17596685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Statins in stroke prevention].
    Gedikli O; Baykan M
    Anadolu Kardiyol Derg; 2008 Jun; 8(3):217-22. PubMed ID: 18524729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid-lowering drugs in ischemic stroke prevention and their influence on acute stroke outcome.
    Fuentes B; Martínez-Sánchez P; Díez-Tejedor E
    Cerebrovasc Dis; 2009; 27 Suppl 1():126-33. PubMed ID: 19342842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of early statin therapy in patients with ischemic stroke or transient ischemic attack.
    Chen PS; Cheng CL; Kao Yang YH; Yeh PS; Li YH
    Acta Neurol Scand; 2014 Jan; 129(1):41-8. PubMed ID: 23758549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of pretreatment with statins on the severity of acute ischemic cerebrovascular events.
    Greisenegger S; Müllner M; Tentschert S; Lang W; Lalouschek W
    J Neurol Sci; 2004 Jun; 221(1-2):5-10. PubMed ID: 15178206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The need for wider and appropriate utilization of aspirin and statins in the treatment and prevention of cardiovascular disease.
    Hennekens CH; Schneider WR
    Expert Rev Cardiovasc Ther; 2008 Jan; 6(1):95-107. PubMed ID: 18095910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose atorvastatin and risk of atrial fibrillation in patients with prior stroke or transient ischemic attack: analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial.
    Schwartz GG; Chaitman BR; Goldberger JJ; Messig M
    Am Heart J; 2011 May; 161(5):993-9. PubMed ID: 21570534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [After TIA and stroke: a statin for secondary prevention?].
    MMW Fortschr Med; 2006 Jun; 148(24):10. PubMed ID: 16850798
    [No Abstract]   [Full Text] [Related]  

  • 19. Antihypertensive therapy and the benefits of atorvastatin in the Anglo-Scandinavian Cardiac Outcomes Trial: lipid-lowering arm extension.
    Sever PS; Poulter NR; Dahlof B; Wedel H;
    J Hypertens; 2009 May; 27(5):947-54. PubMed ID: 19318984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Statins in the secondary prevention of stroke: New evidence from the SPARCL Study].
    Castilla-Guerra L; Fernández-Moreno Mdel C; López-Chozas JM
    Clin Investig Arterioscler; 2016; 28(4):202-8. PubMed ID: 26150172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.